Brief Communication
detects MTB and RIF resistance within 3 h. As the limit of detection of the assay is 131 CFU/ml of the specimen, it is expected to have better accuracy in paucibacillary diseases such as skeletal TB. As treatment of skeletal TB is comparatively lengthy, early and confirmed laboratory diagnosis with knowledge of drug resistance is the need of the hour. Data on drug-resistant skeletal TB are lacking in India. Hence, this retrospective study was undertaken to compare the yield of case detection using microscopy, culture and Xpert assay in specimens received from clinically suspected cases of skeletal TB and to determine proportion of RIF resistance in skeletal TB.
meThOds
Pus and tissue biopsy specimens collected in a sterile container during surgical debridement from suspected skeletal TB cases are routinely submitted to the laboratory for the detection of MTB. Tissue specimens are submitted in sterile normal saline. Microscopy by Ziehl-Neelsen staining was performed as per the RNTCP guidelines. [11] Culture was done on Lowenstein-Jensen medium after decontamination by NALC-NaOH method. [12] Xpert MTB/RIF assay was performed as per the guidelines issued by the WHO for processing extrapulmonary specimens. [13] This assay provided the result as 'MTB detected' or 'MTB not detected'. When MTB is detected in the sample, it provides a semi-quantitative estimation of bacterial load as very low, low, medium and high as well as RIF sensitive/resistant. All the results were entered in the laboratory register.
Ethics committee permission was obtained to conduct a retrospective analysis of the results of microscopy, culture and Xpert assay performed on specimens from suspected cases of skeletal TB over 2 years (January 2016-December 2017). Percentage positivity and incremental yield using Xpert MTB/RIF assay were determined. Chi-square test was applied to determine significance of difference in number of cases detected. P < 0.05 was considered statistically significant.
resuLTs
Two hundred and ten consecutive cases of skeletal TB referred to this laboratory over 2 years were included in the study. An equal number of specimens were processed. Nine (4.28%) specimens were excluded from analysis due to inconclusive results in either culture or Xpert assay. Of the 201 cases included for analysis, 119 were male and 82 were female. About 48% of patients were >60 years of age, 49% were between 30 and 60 years and 3% were <14 years old. One hundred and twenty-five (63.19%) specimens were pus and 76 (37.81%) were biopsy from tissue. Anatomically, majority of the specimens were obtained from the spine (55.72%) followed by knee joint (21.39%). Of the 201 specimens processed, MTB was detected in 67 (33.33%) of specimens by any of the three methods. About 48.68% (37/76) of tissue biopsy and 24% (30/125) of pus specimens were positive for MTB.
Microscopy by fluorescent staining was detected acid-fast bacilli only in 7 (3.48%) specimens. All of them were pus specimens. Xpert assay was detected MTB in 67 (33.33%) specimens of which 53 (47.32%) were specimens from the spine [ Table 1 ]. 38.81%, 55.22% and 5.97% specimen had very low, low and medium load of bacilli, respectively [ Table 2 ]. High load of bacilli was not detected in any specimen. Ten (14.92%) cases were detected as RIF-resistant MTB by Xpert assay.
Culture on Lowenstein-Jensen medium was detected MTB in 66 (32.83%) specimens. When the results of Xpert assay and culture were compared, three discordant results were observed. Xpert assay was detected two specimens more than culture. One specimen was positive by culture and negative by Xpert assay.
disCussiOn
Skeletal TB is the third most common type of EPTB after pleural and lymphatic disease. Spine-and weight-bearing joints are the most vulnerable sites of infection. [14] Skeletal TB is a chronic infection, which if not diagnosed and treated properly, leads to lifetime morbidity in the form of deformity or neurological deficit. [14] The development of Xpert assay for the diagnosis of TB was a breakthrough due to its rapid turnaround time of 3 h and better accuracy. [15] Very few studies are available to determine the contribution of Xpert assay in providing a definitive diagnosis of skeletal TB. In the present study, common site affected by TB in clinically suspected skeletal TB cases referred to the laboratory had was spine (47.32%) followed by large joints. Skeletal TB generally arises from reactivation of bacilli lodged in bone during mycobacteraemia of primary infection. Rarely TB bacilli travel from the lung to the spine along the venous plexus or by lymphatic drainage to the paraortic lymph node. [16] The predilection of the TB bacilli for the spine and large joints is attributed to the rich vascular supply of vertebra and growth plates of long bones, respectively. [15] Spinal TB usually involves more than one vertebra because the segmental artery bifurcates to supply two adjacent vertebrae. [17, 18] This causes major problem with weight-bearing capacity of the spine, and the patient may become bedridden or results in and major deformity in posture.
Very low sensitivity of 10.77% was observed by microscopy using Ziehl-Neelsen staining in comparison with culture. All the smear-positive specimens were pus indicating that microscopy does not play a major role in TB diagnosis in biopsy of bone tissue. Very low smear positivity in skeletal TB may be attributed to the paucibacillary nature of the disease. This finding is supported by the results of Xpert assay wherein the bacillary load in MTB-positive specimens was either very low (38.81%) or low (55.23%). Another reason may be difficulty in breaking a very small piece of the bone tissue obtained during biopsy.
Of the 201 specimens, 67 (33.33%) were positive by Xpert assay and 66 (32.83%) were detected by culture. Three discordant results were obtained and all three specimens were bone tissue. Xpert assay was detected two cases more than culture. These two cases would have been missed without Xpert assay. These two specimens were very small pieces of vertebral tissue obtained during surgery. Culture is considered as gold standard for the diagnosis of active TB. However, decontamination done for any type of culture is a very critical step which affects the growth of bacilli. Considering the paucibacillary nature of skeletal TB, extended decontamination even for few minutes may kill the TB bacilli giving negative results in culture. In the present study, decontamination process did not exceed more than 20 min. Negative results in culture may also be due to uneven distribution of the bacilli in a very hard bone tissue. Furthermore, bacilli have a tendency to form clumps. Tissue specimens received in sterile container with approximately 2 ml of sterile normal saline were homogenised using a sterile tissue homogeniser and processed for Xpert assay. Proper care was taken to avoid transferring any clumps of tissue which have not been properly homogenised in the cartridge. Better homogenisation and liquefaction of the sample are probably obtained using sample reagent of Xpert assay than culture. In the present study, Xpert assay may have received a larger portion of tissue as compared to culture due to the more rapid turnaround time and simultaneous detection of RIF resistance. Xpert assay had sensitivity of 97.01%, specificity of 99.25%, positive predictive value of 98.48% and negative predictive value of 98.52% in comparison with culture. It is higher than pooled sensitivity and specificity of 81% and 83%, respectively, in a meta-analysis. [19] Variable results were documented in other studies done on Xpert assay and other PCR techniques. [20] [21] [22] One specimen was positive by culture and negative by Xpert assay. This specimen was tissue biopsy from cervical vertebra. Xpert assay result was valid as sample processing control was amplified and probe check control also worked. False-negative Xpert assay result may be attributed to the presence of lesser number of bacilli compared to limit of detection of the assay. It may also be due to uneven distribution of mycobacteria in tissue samples, presence of extensive necrosis in the tissues and presence of inhibitors which inhibited the amplification of the MTB genome without any effect on the internal control.
One of the important advantages of Xpert assay is that RIF status of the MTB detected in the specimen is available at the same time as detection. Of the 67 specimens positive for MTB, 10 (14.92%) were RIF resistant. These patients were put on treatment for RIF-resistant TB within 24 h of submitting the sample to the laboratory due to the rapidity of Xpert assay. Two specimens showed RIF indeterminate result with very low load of bacilli. On retesting, they were reported as RIF sensitive. Data on drug resistance in skeletal TB are lacking in literature.
Major problem with extrapulmonary specimens is the presence of blood in the specimen. As skeletal specimens are collected Spine  112  53  9  42  2  21  28  4  Knee  43  4  1  3  0  1  3  0  Elbow  8  2  0  2  0  1  1  0  Hip  10  2  0  2  0  1  1  0  Wrist  11  2  0  2  0  1  1  0  Shoulder  7  3  0  3  0  0  3  0  Sacroiliac joint  3  1  0  1 by either imaging-guided needle biopsy or surgical biopsy from the affected site, they usually contain significant amount of blood which interferes with Xpert assay giving 'ERROR' result. In the present study, 'ERROR' was obtained in 20 (9.52%) specimens of which 11 could be retested. MTB was detected in two of these specimens, both being RIF sensitive.
Of the total 201 specimens, 125 (62.19%) were pus and 76 (37.81%) were tissue specimens. Positivity was better in tissue specimens (48.68%) as compared to pus specimens (24%). Tissue specimens giving positive results were pieces of vertebral tissue from different locations. RIF resistance was detected in 20% and 10.81% of pus and biopsy specimens, respectively.
COnCLusiOn
The spine is the most common site involved in skeletal TB. Tissue specimen is better than pus or fluid to obtain early diagnosis. High RIF resistance in skeletal TB, especially spine TB, is an alarming situation. Xpert MTB/RIF assay is a point of care test and its ability of rapid and simultaneous detection of MTB and RIF resistance in comparison with culture as a gold standard makes it a useful diagnostic tool in skeletal TB.
